These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 21972424)

  • 1. Atorvastatin therapy decreases androstenedione and dehydroepiandrosterone sulphate concentrations in patients with polycystic ovary syndrome: randomized controlled study.
    Sathyapalan T; Smith KA; Coady AM; Kilpatrick ES; Atkin SL
    Ann Clin Biochem; 2012 Jan; 49(Pt 1):80-5. PubMed ID: 21972424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin reduces malondialdehyde concentrations in patients with polycystic ovary syndrome.
    Sathyapalan T; Shepherd J; Coady AM; Kilpatrick ES; Atkin SL
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3951-5. PubMed ID: 22879630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of atorvastatin on testosterone levels.
    Shawish MI; Bagheri B; Musini VM; Adams SP; Wright JM
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013211. PubMed ID: 33482034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible metformin effect on adrenal androgens during pretreatment and IVF cycle in women with polycystic ovary syndrome.
    Kjøtrød SB; Sunde A; von Düring V; Carlsen SM
    Fertil Steril; 2009 Feb; 91(2):500-8. PubMed ID: 18304542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS; Thompson DL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T; Dehghan-Kooshkghazi M
    Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin increases 25-hydroxy vitamin D concentrations in patients with polycystic ovary syndrome.
    Sathyapalan T; Shepherd J; Arnett C; Coady AM; Kilpatrick ES; Atkin SL
    Clin Chem; 2010 Nov; 56(11):1696-700. PubMed ID: 20817794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of atorvastatin in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled study.
    Sathyapalan T; Kilpatrick ES; Coady AM; Atkin SL
    J Clin Endocrinol Metab; 2009 Jan; 94(1):103-8. PubMed ID: 18940877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin therapy worsens insulin sensitivity in women with polycystic ovary syndrome (PCOS): a prospective, randomized, double-blind, placebo-controlled study.
    Puurunen J; Piltonen T; Puukka K; Ruokonen A; Savolainen MJ; Bloigu R; Morin-Papunen L; Tapanainen JS
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4798-807. PubMed ID: 24152688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome.
    Lerchbaum E; Schwetz V; Giuliani A; Pieber TR; Obermayer-Pietsch B
    Fertil Steril; 2012 Nov; 98(5):1318-25.e1. PubMed ID: 22835450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome.
    Azziz R; Ehrmann DA; Legro RS; Fereshetian AG; O'Keefe M; Ghazzi MN;
    Fertil Steril; 2003 Apr; 79(4):932-7. PubMed ID: 12749433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variants in SULT2A1 affect the DHEA sulphate to DHEA ratio in patients with polycystic ovary syndrome but not the hyperandrogenic phenotype.
    Louwers YV; de Jong FH; van Herwaarden NA; Stolk L; Fauser BC; Uitterlinden AG; Laven JS
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3848-55. PubMed ID: 23861462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Androgen and 17-hydroxyprogesterone concentrations in blood serum versus menstrual patterns in women with polycystic ovary syndrome (PCOS)].
    Rudnicka E; Kunicki M; Radowicki S
    Ginekol Pol; 2010 Oct; 81(10):745-9. PubMed ID: 21117302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS.
    Chen F; Chen M; Zhang W; Yin H; Chen G; Huang Q; Yang X; Chen L; Lin C; Yin G
    J Ovarian Res; 2021 Feb; 14(1):32. PubMed ID: 33583431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.
    Azziz R; Black VY; Knochenhauer ES; Hines GA; Boots LR
    J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of glycemic variations on the regulation of androgen metabolism in obese women with polycystic ovary syndrome.
    Ludwig AK; Goharian LG; Dietze T; Tauchert S; Rudolf S; Diedrich K; Schweiger U; Oltmanns KM
    Fertil Steril; 2009 Jul; 92(1):271-6. PubMed ID: 18692843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Metformin Treatment on Soluble Leptin Receptor Levels in Women with Polycystic Ovary Syndrome.
    Liu RB; Liu Y; Lv LQ; Xiao W; Gong C; Yue JX
    Curr Med Sci; 2019 Aug; 39(4):609-614. PubMed ID: 31346998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical Length and Androgens in Pregnant Women With Polycystic Ovary Syndrome: Has Metformin Any Effect?
    Shetelig Løvvik T; Stridsklev S; Carlsen SM; Salvesen Ø; Vanky E
    J Clin Endocrinol Metab; 2016 Jun; 101(6):2325-31. PubMed ID: 26835542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In PCOS patients the addition of low-dose spironolactone induces a more marked reduction of clinical and biochemical hyperandrogenism than metformin alone.
    Mazza A; Fruci B; Guzzi P; D'Orrico B; Malaguarnera R; Veltri P; Fava A; Belfiore A
    Nutr Metab Cardiovasc Dis; 2014 Feb; 24(2):132-9. PubMed ID: 23845740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of overnight dexamethasone suppression on the adrenal androgen response to an oral glucose tolerance test in women with and without polycystic ovary syndrome.
    Buyalos RP; Geffner ME; Azziz R; Judd HL
    Hum Reprod; 1997 Jun; 12(6):1138-41. PubMed ID: 9221990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.